Navigation Links
Sigma-Tau Pharmaceuticals Announces Approval for New Manufacturing Process for ONCASPAR® (Pegaspargase) Primary Ingredient
Date:4/18/2011

GAITHERSBURG, Md., April 18, 2011 /PRNewswire/ -- Sigma-Tau Pharmaceuticals, Inc. is pleased to announce that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture L-asparaginase, the primary ingredient in the oncology medicine ONCASPAR® (pegaspargase).  ONCASPAR is the only FDA-approved PEGylated formulation of L-asparaginase which is a key component in the treatment of acute lymphoblastic leukemia (ALL). The attempt to secure approval to manufacture L-asparaginase came after the previous supplier decided to cease production, leading to a three-year development effort to create a comparable active ingredient.  The approval averts a potentially dangerous drug shortage situation in the U.S. which could have affected thousands of patients with ALL.

"To get a complex biologic medicine such as this exactly right takes a great deal of work for both the manufacturer and the FDA," said Gregg Lapointe, Chief Executive Officer, Sigma-Tau Pharmaceuticals, Inc.  "We are pleased to announce that with this approval, there will be no interruption in either the production of the medicine or in the treatment of patients with ALL."

L-asparaginase is an enzyme that depletes the amino acid asparagine, which certain leukemic cells are dependent upon for survival.  L-asparaginase was first approved in 1978 as a treatment for ALL. In 1994, the FDA approved the PEGylated formulation of the medicine (ONCASAPR) which has the unique therapeutic advantages of sustained duration and prolonged effect over the native L-asparaginase, resulting in enhanced convenience for patients and providers.  ONCASPAR is given to patients with ALL as part of a multi-agent chemotherapeutic treatment regimen.  Administering L-asparaginase results in the depletion of asparagine circulating in the blood, which starves the leukemic cells and results in their death.  ONCASPAR was updated to first-line indication in 2006.


'/>"/>
SOURCE Sigma-Tau Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. DOR BioPharma Announces Private Equity Financing of $3.85 Million with its Partner Sigma-Tau and Other Institutional Investors
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
6. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
11. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... May 21, 2015 Research ... addition of the "North American Active Wound ... Application (Surgical Wound, & Ulcer), by End-User (In-Patient, ... report to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... is estimated to grow at a CAGR of ...
(Date:5/21/2015)... Research and Markets ... of the "Arthroscopy Devices Markets Worldwide" ... http://photos.prnewswire.com/prnh/20130307/600769) , ,The purpose of this report ... market for Arthroscopy Devices. The report discusses ... market for these products. , ,Product - ...
(Date:5/21/2015)... 21, 2015  Cardica, Inc. (Nasdaq: CRDC ) today ... Watson , the company,s vice president of operations, was granted ... stock, at a per share exercise price of $0.43, the ... was granted pursuant to Cardica, Inc.,s Inducement Plan, which was ... under Rule 5653(c)(4) of the Nasdaq Global Market for equity ...
Breaking Medicine Technology:North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 3Cardica Announces New Employment Inducement Grant 2
... 14, 2012  Natural Alternatives International, Inc. ("NAI") (NASDAQ: ... of customized nutritional supplements, announced today that on February ... DNP International Co., Inc. in U.S. District Court for ... U.S. Patent No. 8,067,381 ("the ,381 patent"), entitled "Methods ...
... Alliance for Safe Biologic Medicines will have an ... focusing on biologic medicines and pharmacovigilance.  Dr. Richard Dolinar, a ... the newly released FDA draft guidances for manufacturers ... is it and why is it important? ...
Cached Medicine Technology:Natural Alternatives International, Inc. Files Patent Infringement Claim Against DNP International Co., Inc. 2Natural Alternatives International, Inc. Files Patent Infringement Claim Against DNP International Co., Inc. 3Alliance for Safe Biologic Medicines Announces New Webinar on February 16 2
(Date:5/26/2015)... May 26, 2015 The Brain Aneurysm ... Boston Pops and their renowned Conductor Keith Lockhart will ... Wednesday evening, June 10, 2015—the 4th Annual Brain ... Boston Pops Night is set to feature an exclusive ... Conductor Keith Lockhart who tragically lost his sister-in-law to ...
(Date:5/26/2015)... May 26, 2015 The professionals from ... at it again, helping local rescue pets with a ... Local dentists, Kirk Kimmerling DDS, Suzanna Aguilera DMD and ... Peckich DVM donating 100% of proceeds from the extravaganza. ... the parking lot to help save unwanted, local animals. ...
(Date:5/26/2015)... May 26, 2015 Carl W. Berk, ... Surgical Center in Pinehurst, N.C. have launched a Balloon ... patients about chronic sinusitis and the benefits of Balloon ... be used to determine if someone is a good ... symptoms and other factors that can contribute to chronic ...
(Date:5/25/2015)... According to the National Library of Medicine, one ... degenerative eye disease. The National Library of Medicine also states ... dyskinesia , a rare disorder that causes sporadic muscle behavior ... these two diseases are more than a statistic – they’re ... shoes with his new autobiography “ The Way I ...
(Date:5/25/2015)... NY (PRWEB) May 26, 2015 ... Anne King as a 2015-2016 inductee into ... is recognized with this prestigious distinction for leadership in ... exclusively for professional women, boasting more than 700,000 members ... pleased to welcome Anne into this exceptional group of ...
Breaking Medicine News(10 mins):Health News:Boston Pops & Renowned Conductor Keith Lockhart to Join the Brain Aneurysm Foundation for the 4th Annual Brain Aneurysm Foundation Night at the Pops 2Health News:"Rescue Animal Cookout" Announced at Verde Pointe Professional Park on June 25, 2015 2Health News:Pinehurst Surgical Sinus Center Launches Pinehurst Balloon Sinuplasty Website 2Health News:Joseph K. Chan Finds Faith from Disability in New Autobiography 2Health News:National Association of Professional Women Inducts Anne King, Operating Principal at Keller Williams, Into its VIP Professional Woman of the Year Circle 2
... Pick Their AntioxidantPLANO, Texas, Feb. 2 Just ... the 7UP brand is romancing consumers with its ... pink-hued, crisp and refreshing beverage combines the delicious ... flavor and the bonus of antioxidant Vitamin E.(Logo: ...
... - A new technique combining computed tomography (CT) with ... remove small lung nodules without the need for a ... in the February issue of Radiology . , ... locate and remove than larger nodules," said the study,s ...
... When a first hip replacement fails, patients may be concerned ... and that the prognosis is poor. However, a research study ... Journal of Bone and Joint Surgery suggests that this ... University Medical Center examined their results using one of the ...
... of an SNM-sponsored centralized multi-center investigational new drug ... approval of multi-center Chemistry Manufacturing and Controls (CMC) ... of an important FDA IND review process for ... has agreed to allow multiple sources of FLT ...
... VICTORIA, British Columbia, Feb. 2 Agresso has ... another win in the health care,sector. After a ... Enterprise Resource Planning (ERP) solution over a number ... Navision, in a deal valued at more,than $1M. ...
... Inc. (OTC,Bulletin Board: UVICF) (TSX Venture Exchange: UVI) Board of ... per common share,payable February 27, 2009 to stockholders of record ... "We are pleased to continue the U.S. ... of U.S. $0.36 per share provides a,dividend yield of 12% ...
Cached Medicine News:Health News:7UP Gives Consumers a New Reason to Fall in Love - New Cherry 7UP Antioxidant 2Health News:Microcoils help locate small lung nodules 2Health News:Cementless cup device developed for hip replacements shows durability after more than 20 years 2Health News:FDA embraces a new review process and approves SNM's multi-center IND for FLT 2Health News:Agresso Wins Another $1 Million+ Deal in Health Care Sector 2Health News:Agresso Wins Another $1 Million+ Deal in Health Care Sector 3Health News:Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: